Marked increase in first-time HIV diagnoses in Ontario, 2002.

Slides:



Advertisements
Similar presentations
Uptake of HIV testing among pregnant women in Ontario: Results from the HIV seroprevalence study to June 2002 Robert S. Remis, Carol Swantee, Carol Major,
Advertisements

Epidemiological features of HIV infection among pregnant women in Botswana Yadav Bindeshwar P Anderson Marina G Mine Madisa Moyo Sikhulile Seipone Khumo.
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Epidemiology of HIV-2 infection in the U.S, Lata Kumar MS, MPH Richard Selik MD Division of HIV/AIDS Prevention National Center for HIV/AIDS,
Late HIV Diagnoses, Georgia,
HIV Infection in Michigan January 1, 2012 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases.
Broward County Excluding Dept. of Corrections HIV/AIDS Epidemiology Partnership 10 Florida Department of Health HIV/AIDS & Hepatitis Section Annual data.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario Robert S. Remis MD Department.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario: Update to 2002 Robert S.
1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Emerging Trends of HIV/AIDS in New York City Chris Williams, MPH NYC DOHMH.
HIV Surveillance Report, 2012 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance System.
Description of fracture with endocrine therapy use in older breast cancer survivors in a population-based setting Taryn Becker 123, Geoff Anderson 123,
HIV/AIDS in Michigan January 1, 2010 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases Bureau.
HIV infection among men who have sex with men in Ontario: Analysis by race/ethnicity Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring.
Epidemiology of Hepatitis C Infection in Canada Robert S. Remis MD, MPH, FRCPC Department of Public Health Sciences University of Toronto 1st Canadian.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
HIV Care Continuum, District 8- 2 Southwest (Albany), Georgia, 2012.
National Audit Group National Audit of Sexual Healthcare for People with HIV Infection National Audit Group British Association for Sexual Health & HIV.
Gonorrhea Increases In Washington State: Gonorrhea Increases In Washington State: Analyses for intervention planning May 2011 Mark R. Stenger Infectious.
Bias in estimates of HIV incidence based on the detuned assay: A proposed solution Robert S Remis, Robert WH Palmer, Janet M Raboud Department of Public.
Epidemiologic overview of HIV/AIDS in Ontario and Toronto: 2004 update Robert S. Remis MD, MPH, FRCPC, Maraki Fikre Merid BSc Ontario HIV Epidemiologic.
Using the detuned assay to determine HIV incidence in Ontario: Results and methodologic perspectives Robert S. Remis, Carol Major, Carol Swantee, Margaret.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
Increasing HIV testing among pregnant women: Results from the Ontario HIV seroprevalence study Robert S. Remis, Carol Swantee, Maraki Fikre Merid, Robert.
Trends in HIV incidence in Ontario based on the detuned assay: Update to October 2000 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Evelyn.
HIV Care Continuum, District 10 Northeast (Athens), Georgia, 2012.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
HIV infection among persons in Ontario infected through heterosexual contact Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit.
HIV/AIDS Epidemiology Partnership 1 Escambia, Okaloosa, Santa Rosa and Walton Counties Excluding Dept. of Corrections Florida Department of Health HIV/AIDS.
Trends in HIV incidence in Ontario based on the detuned assay: Update to December 2002 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Robert.
Trends in HIV diagnoses in Ontario, 2000­2004 Robert S. Remis, Jane Njihia, Carol Swantee, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit,
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2004 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
HIV surveillance in Northern Ireland 2013 An analysis of data for the calendar year 2012.
Florida Department of Health HIV/AIDS & Hepatitis Program Annual data trends as of 12/31/2011 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
Laboratory Enhancement Study: Using the detuned assay to determine HIV incidence in Ontario October 1999 – July 2000 Robert S. Remis, Carol Major, Carol.
The HIV epidemic in Ontario: 2004 update Robert S. Remis, MD, MPH, FRCPC Ontario HIV Epidemiologic Monitoring Unit Department of Public Health Sciences,
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
HIV Infections in Utah: 2014 Epidemic Update. Cases – persons diagnosed with HIV and reported to public health Rates – cases per 100,000 populations Sex.
Trends in Neisseria gonorrhoeae Incidence in Washington State Region X GC Meeting Trends in Neisseria gonorrhoeae Incidence in Washington State Region.
Why Late Diagnosis of HIV? Dr Faiza Khan Consultant in Public Health Kent County Council.
Viral load distribution 2012 among persons living with HIV and persons newly diagnosed Georgia, 2011.
Hardee, Highlands and Polk Counties Excluding Dept. of Corrections HIV/AIDS Epidemiology Partnership 14 Florida Department of Health HIV/AIDS & Hepatitis.
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
Uptake of HIV testing among pregnant women in Ontario: Results from the HIV seroprevalence study to December 2000 Robert S. Remis, Carol Major, Margaret.
The HIV epidemic in Ontario: An epidemiologic update Robert S. Remis, MD, MPH, FRCPC, Department of Public Health Sciences, University of Toronto Presentation.
Contents - HIV global slides
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
HIV surveillance in Northern Ireland 2015
HIV in Ireland Quarter 1& Provisional Data 15th November 2017
Table 1: New HIV diagnoses, by UK country,
HIV surveillance in Northern Ireland 2014
Latest update to the National Outbreak Response group on recent trends in HIV, STIs and Hepatitis among men who have sex with men (MSM) in Ireland June.
HIV Diagnosis and the Cascade of Care in Ontario
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
WHO HIV update July 2018 Global epidemic Global progress and cascade
Note: 2017 data are provisional
Contents - HIV global slides
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2003 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Epidemiologic Update on the HIV Epidemic in Ontario
Health Protection Surveillance Centre
Contents - HIV global slides
HIV surveillance in Northern Ireland 2018
Annual trends update: HIV, Hepatitis and STIs among MSM in Ireland (to the end of 2017) December 2018.
Contents - HIV global slides
HIV Recency Testing in Rwanda
Presentation transcript:

Marked increase in first-time HIV diagnoses in Ontario, 2002

Acknowledgements Public Health Laboratory staff, Ontario Ministry of Health and Long-Term Care Public Health Laboratory staff, Ontario Ministry of Health and Long-Term Care Keyi Wu, programming Keyi Wu, programming Mark Fisher, systems consulting and custom download Mark Fisher, systems consulting and custom download

Background In Ontario, HIV diagnostic testing is conducted at the HIV Laboratory and regional labs In Ontario, HIV diagnostic testing is conducted at the HIV Laboratory and regional labs Use HIV Laboratory data to monitor the HIV epidemics in Ontario Use HIV Laboratory data to monitor the HIV epidemics in Ontario In late 2002, observed a marked increase in first-time diagnoses in the first three quarters In late 2002, observed a marked increase in first-time diagnoses in the first three quarters

Study objectives 1. To characterize the increase in first-time HIV diagnoses at the Ontario HIV Laboratory in To better understand to what extent this increase was due to increased HIV testing or HIV incidence

Methods Examined first-time HIV-positive and total HIV tests from 1985 to 2002 Examined first-time HIV-positive and total HIV tests from 1985 to 2002 First-time HIV positive: confirmed positive with no link to a previous positive result in database and no other evidence of previous HIV-positive test in Ontario First-time HIV positive: confirmed positive with no link to a previous positive result in database and no other evidence of previous HIV-positive test in Ontario Based on the observed pattern, defined the period of increase as calendar year 2002 Based on the observed pattern, defined the period of increase as calendar year 2002 Compared HIV test results for 2002 to those in 2001 by sex, age, exposure category, reason for testing, health region and seroconverter or not Compared HIV test results for 2002 to those in 2001 by sex, age, exposure category, reason for testing, health region and seroconverter or not

RESULTS First-time HIV positives and HIV tests by year, Ontario, Year of testing First-time HIV postive tests All HIV tests First-time HIV positivesAll HIV tests

First-time HIV positives and HIV tests by quarter, Ontario, Q11999Q21999Q31999Q42000Q12000Q22000Q32000Q42001Q12001Q22001Q32001Q42002Q12002Q22002Q32002Q4 Year-Quarter Number of First-time HIV positive tests Number of all HIV tests First-time HIV positivesAll Tests

First-time HIV diagnoses by sex Ontario, 2002 versus 2001 Year Female Male Unknown Total , ,238 Relative rate (2002/2001) Excess tests ( )

First-time HIV diagnoses by health region Ontario, 2002 versus 2001 Year Northern Eastern Ottawa Central East Toronto South Central Other Other West West Relative rate (2002/2001) Excess tests ( ) Proportion of Excess0.80%6.90% 83.70% 8.60%

First-time HIV diagnoses by exposure category by year, Ontario, Year of testing Number of first-time positives UnknownMSMIDUEndemicHR HeteroLR Hetero

First-time HIV diagnoses by exposure category, Ontario, 2002 versus 2001 Year MSM IDU Endemic HR hetero LR hetero Unknown Relative rate (2002/2001) Excess tests ( ) Proportion of Excess42.7% 0.9% 4.0% 0.9% 3.6% 46.2%

First-time HIV diagnoses by reason for testing, Ontario, 2002 versus 2001 Year Donor of blood, tissue Diagnostic Follow-up Insurance Prenatal semen Visa (Known) Unknown Relative rate (2002/2001) Excess tests ( )

Is the the increase due to an increase in HIV testing?

Summary of increase in major categories

Proportion of seroconverters, linked and in progress, among first-time HIV diagnoses 2002 versus Relative rate Excess

Summary of observations Excess of 220 (+22%) first-time HIV diagnoses from 2001 to 2002 Excess of 220 (+22%) first-time HIV diagnoses from 2001 to 2002 Exposure category: MSM and persons from HIV-endemic regions (PHER) highest Exposure category: MSM and persons from HIV-endemic regions (PHER) highest Health region: Toronto and Central West highest Health region: Toronto and Central West highest Reason for test, visa applicants highest Reason for test, visa applicants highest Reasons for testing and exposure categories were mutually exclusive, e.g., no MSM among visa applicants Reasons for testing and exposure categories were mutually exclusive, e.g., no MSM among visa applicants Proportion of excess: MSM 43%, PHER 4%, visa 51% Proportion of excess: MSM 43%, PHER 4%, visa 51%

Conclusions Increase among visa applicants entirely due to increase in HIV testing Increase among visa applicants entirely due to increase in HIV testing Among MSM and PHER, increase in HIV diagnoses Among MSM and PHER, increase in HIV diagnoses not due to increased HIV testing not due to increased HIV testing Increases in these groups may be due to selective increased HIV testing in persons at high risk for HIV infection Increases in these groups may be due to selective increased HIV testing in persons at high risk for HIV infection Also, evidence of increased HIV incidence in MSM Also, evidence of increased HIV incidence in MSM Thus, both increased HIV testing and increased HIV incidence responsible for observed increase in HIV diagnoses Thus, both increased HIV testing and increased HIV incidence responsible for observed increase in HIV diagnoses Relative importance not clear; requires further study Relative importance not clear; requires further study